ARCHIVES

FDA Proposes New Nonclinical Lab Regs

This article is from The Cancer Letter archive.

Vol. 02 No. 48 | November 26, 1976

Download PDF Visit The Full Archive

Related Articles

Budget Manipulations “Wreaking Havoc,” Korn Tells NCAB; Legal Actions Being Considered

February 13, 1987

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

Marijuana Ingredient Promotes Tumor Growth, Study Finds.

June 23, 2000

Breast Cancer Vs. Other Cancers In Budget Showdown

July 3, 1992

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies

May 11, 2012